Keytruda Plus mRNA Vaccine Shows Promise in Skin Cancer Trial
Merck's Keytruda paired with a personalized mRNA vaccine produced 'promising' results in a skin cancer trial, the company reported via Yahoo Finance. The combination is the most-watched adjuvant mela…